BRAF and colorectal cancer: In the biomarkers profile of colorectal cancer patients (dMMR, KRAS, NRAS, BRAF) in the population of the study, the only biomarker used was KRAS, which was not routinely available and was only given to a few patients through a commercial program unrelated to the researchers; therefore, not all exploratory outcomes were reached, and some results were inconclusive.